New study reviews Clot-Busting treatments for kids with stroke
NCT ID NCT03887143
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviewed medical records of 70 children under 18 who received clot-busting drugs or mechanical clot removal for a stroke. Researchers measured how quickly treatment was given and looked for side effects like bleeding. The goal is to better understand the safety and timing of these treatments in children.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- clot-busting drugs (intravenous thrombolysis) and/or mechanical clot removal (thrombectomy)
- What this could lead to
- If successful, this could help doctors know the best way to treat children having a stroke, potentially improving recovery.
- What could go wrong
- This is a small, retrospective study that only looks at past cases, so it cannot prove which treatment is best. Results may not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIAL ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Necker- Enfants Malades Hospital
Paris, Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.